期刊文献+

HPV-16E4原核表达系统的建立和表达特性研究 被引量:2

Analysis of Protein Expression Feature and Construction of Procaryotic Expression System for Human Papillomavirus Type 16 (HPV-16) E4 Gene
暂未订购
导出
摘要 目的克隆人乳头瘤病毒-16型(HPV-16)E4基因(E4),构建E4蛋白表达重组工程菌,探索表达条件和鉴定表达产物特性。方法以临床HPV-16阳性宫颈炎患者上皮细胞提取物为模板,PCR扩增E4完整基因,并定向克隆到pET32a(+)原核表达质粒中,经双酶切和测序鉴定后转入大肠杆菌BL-21(DE3),获得工程菌(BL-21/E4)。经IPTG诱导,表达蛋白用SDS-PAGE和Westernblot鉴定。结果克隆到完整E4基因为342bp,与HPV-16东亚型的同源性为99%,与其他HPV16型的同源性高于97%。在28℃和37℃,0.1mmol/L的IPTG诱导18h时,重组蛋白(rE4)表达量分别占菌体总蛋白的12.2%和12.8%;SDS-PAGE和Westernblot证明rE4蛋白与表达载体的标签蛋白形成相对分子质量约34×103的可溶性融合蛋白(rE4/His)。结论成功构建了表达带标签的融合重组蛋白(rE4/His)的重组大肠杆菌BL-21/E4表达系统,这为高纯度HPV-16E4蛋白的制备和相关研究奠定了基础。 Objective To clone the E4 gene (E4) from human papillomavirus type 16(HPV-16), construct the engineering bacteria of prokaryotic, expression, and explore the expression conditions and the characters of expression product. Methods The complete E4 gene was cloned by PCR from the sample cell extract of clinical cervical disease that was the positive HPV-16 confirmed by Real-PCR. The E4 DNA fragment was inserted into the pET32a(+) to construct a prokaryotic expression plasmid, called as pET32/E4. Then the expression plasmids were transferred into competent E. coli BL21 (DE3). Recombinant DNA was identified by Bgl Ⅱ and Hind Ⅲ digestion, and then sequencing. The recombine bacterium, BL21/E4, was induced with different IPTG concentrations at different temperatures. The expressed proteins were checked and analyzed by SDS-PAGE and Gel-Pro Analyzer 4. His-tag of BL21/E4 expression protein was hybridized to McAb. Results The E4 gene cloned by PCR was about 342 bp. The blasted result showed that the E4 gene had 99% homology .of HVP-16 DNA sequence, the cloned E4 gene expression frame was the same as HVP-16 East Asia strain's. Compared with other HPV-16 strains in GenBank, the homology of E4 gene was above 97%. pET32/E4 could express recombinant E4 (rE4) in BL21. The highest expression, which was 12.2% or 12.8% of total bacterial proteins respectively, was gotten when BL21/ E4 was induced by 0. 1 mmol/L IPTG at 28 ℃ or 37 ℃ for 18 hours. The results of SDSPAGE and Western blot showed the rE4 was expressed mainly to form the inclusion body, and to fuse with his-tag (rE4/His), that was soluble and had a molecular weight as about 34 KDa. Conclusion We cloned successfully the E4 gene from HPV-16 and constructed the prokaryotic expression E. coli BL21/E4, which could expression rE4 protein fused with his-tag (rE4/His), effectively. The fused protein could react to McAb recognizing His-tag, which was convenience purified by affinity chromatography. The above research results built a good foundation for preparing the high grade of purity E4 protein and developing the relative study.
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2006年第3期361-364,共4页 Journal of Sichuan University(Medical Sciences)
关键词 HPV-16 E4基因 原核表达 Human papillomavirus typel6 E4 gene Prokaryotic expression
  • 相关文献

参考文献11

  • 1Stoler M. The impact of human papillomavirus biology on the clinical practice of cervical pathology. Pathology Case Reviews, 2005,10(3):119-127.
  • 2Stoler M. Human papillomaviruses and cervical neoplasia: A model for carcinogenesis. International Journal of Gynecological Pathology, 2000,19(1):16-28.
  • 3Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol,2002,55(4):244-265.
  • 4Munoz N, Bosch FX, de Sanjose S, et al. Epldemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 2003,348(2):518-527.
  • 5Cooper K, Evans M, Mount S. Biology and evolution of cervical squamous intraepithelial lesions: A hypothesis with diagnostic prognostic implications. Advances in Anatomic Pathology, 2003 ; 10(4) : 200-203.
  • 6Von Knebel, Doeberitz M. Searching for new biomarkers for cervical cancer: molecular accidents and the interplay of papillomavirus oncogenes and epithelial differentiation (Part Ⅰ). Papillomavirus Report,2002; 13(1) : 35-41.
  • 7Crum CP, Barber S, Symbula M, et al. Coexpression of the human papillomaviruses, type 16 E4 and L1 open reading frames in early cervical neoplasia. Virology, 1990,178(1):238-246.
  • 8Doorbar J, Foo C, Coleman N, et al. Characterisation of events during the late stages of HPV16 infection in vivo using high affinity synthetic Fabs to E4. Virology, 1997;238(1):40-52.
  • 9Mark HS. The impact of human papillomaviruse biology on the clinical practice of cervical pathology. Pathology case reviews,2005;10(30) : 119-127.
  • 10Peh WL, Middleton K, Chistense N, et al. Life cycle heterogeneity in animal models of human papillomavirus-associated disease. J Virol,2002,769(5):10401-10416.

同被引文献16

  • 1徐道华,夏永鹏,邱宗荫.子宫颈癌治疗性疫苗研究进展[J].免疫学杂志,2004,20(z1):46-49. 被引量:4
  • 2VAIN P.Plant transgenic science technology[J].Nat Biotechnol,2005,23:1348-1349.
  • 3MARTA H,DAVID R L,ALEJANDRO F.Current methodology for detection,identification and quantification of genetically modified organisms[J].Current Analytical Chemistry,2005,1 (2):203-221.
  • 4BROOKES G,BARFOOT P.The first ten years-global socio-economic and environmental impacts[M].U K:ISAAA Briefs,2006,36.
  • 5VAIN P.Global trends in plant transgenic science and technology (1973-2003)[J].Trends Biotechnol,2006,24:206-211.
  • 6DUNOYER P,HIMBER C,VOINNET O.Induction,suppression and requirement of RNA silencing pathways in virulent agrobacterium tumefaciens infections[J].Nat Genet,2006,38:258-263.
  • 7VAIN P.Thirty years of plant transformation technology development[J].Plant Biotechnol J,2007,5(2):221-229.
  • 8ANKLAM E,GADANI F,HEINZE P,et al.Analytical methods for detection and determination of genetical modified organisms in agricultural crops and plant-derived food products[J].Eur Food Res Technol,2002,214(1):3-26.
  • 9Karlsen F,Kalantari M,Jenkins A,et al.Use of multiple PCR primer sets for optimal detection of human papillomavirus[J].J Clin Microbiol,1996,34(9):2095-2100.
  • 10Clifford GM,Gallus S,Herrero R,et al.Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys:a pooled analysis[J].Lancet,2005,366(9490):991-998.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部